Build Positions in Biotech
As the month of October begins and broader markets sold off, Biotech sectors are still negative/ flat for the year. Market headlines from high prescription drug prices and lawsuits regarding the opioid epidemic have plagued some of the IBB's largest holdings; which have held biotech ETF's down while the S&P reached all time highs.
Fast-Track Synopsis:
LABU Technical Analysis:
Bullish Harmonic Gartley pattern and close to 52-week low.
* 1-year Gartley pattern should move LABU stock price back up to around $40 level (resistance) where we will be watching for a potential breakout
* CCI measured "oversold" with the end of September pullback, CCI-slope is now trending higher,
* This last pullback also measures a double bottom (data points are from Christmas 2018 and present)
* Intra-day bullish RSI divergence, Daily RSI trending higher;
* the MS Signal recently flipped green as of 10/1/2019 and is still indicating a nice swing opportunity to come.
* Three-drives pattern bouncing toward resistance concurrent with double bottom and Gartley pattern.
* Look for the support level (marked (x)) to hold.
See conclusion here!
Please like and follow so we can continue finding awesome charts/ trades. For more pre-researched Biotech trade-ideas click and visit us at MS Money Moves. Thanks in advance everyone!!
Disclosure: I do not own LABU, I may buy or sell within the next 48 hours. This is not a recommendation to buy or sell. Please do your homework before investing.
Fast-Track Synopsis:
- Biotech is a known high volatility trading environment;
- More Investors will become "Traders" with new $0 trading fee platforms from Schwab and TD Ameritrade.
- Once people begin trading stocks, they will find that high volatility is how the "big" day-trade/ swing trading money is made.
- New Med-tech and Biotechnology therapies (i.e. gene therapies, NASH/ NAFLD) are ripening and getting closer to approval.
- There are currently over 240 biotechnology companies with Gene therapy IP
- IP has been growing with RMAT and Breakthrough Designations due to unmet need of new novel treatments;
- As Biotech rolls into year-end, lower interest rates will propel company growth models which I believe will help drive buy outs.
LABU Technical Analysis:
Bullish Harmonic Gartley pattern and close to 52-week low.
* 1-year Gartley pattern should move LABU stock price back up to around $40 level (resistance) where we will be watching for a potential breakout
* CCI measured "oversold" with the end of September pullback, CCI-slope is now trending higher,
* This last pullback also measures a double bottom (data points are from Christmas 2018 and present)
* Intra-day bullish RSI divergence, Daily RSI trending higher;
* the MS Signal recently flipped green as of 10/1/2019 and is still indicating a nice swing opportunity to come.
* Three-drives pattern bouncing toward resistance concurrent with double bottom and Gartley pattern.
* Look for the support level (marked (x)) to hold.
See conclusion here!
Please like and follow so we can continue finding awesome charts/ trades. For more pre-researched Biotech trade-ideas click and visit us at MS Money Moves. Thanks in advance everyone!!
Disclosure: I do not own LABU, I may buy or sell within the next 48 hours. This is not a recommendation to buy or sell. Please do your homework before investing.
相关出版物
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。